Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.41 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.41 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.41 |
| ▸ | MVD | P53602 | 2/20 | 0.40 |
| ▸ | BTN3A1 | O00481 | 1/20 | 0.38 |
| ▸ | GGPS1 | O95749 | 4/20 | 0.37 |
| ▸ | FDPS | P14324 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14816068 | 0.85 | BTN3A1 (0.44) | LPAR3LPAR1LPAR2MVDBTN3A1 | |
| Pent-4-Ynyl Diphosphate SCHEMBL1652909 | 0.81 | BTN3A1 (0.46) | LPAR3LPAR1LPAR2MVDBTN3A1 | |
| SCHEMBL8861514 | 0.78 | MVD (0.41) | LPAR3LPAR1LPAR2MVDBTN3A1 | |
| SCHEMBL2869539 | 0.77 | LPAR3 (0.67) | LPAR3LPAR1LPAR2MVDBTN3A1 | |
| Triphosphate SCHEMBL5052598 | 0.77 | MMP1 (0.44) | LPAR3LPAR1LPAR2MVDBTN3A1 | |
| Triphosphate SCHEMBL5052601 | 0.77 | MMP1 (0.44) | LPAR3LPAR1LPAR2MVDBTN3A1 | |
| SCHEMBL16417850 | 0.76 | LPAR3 (0.47) | LPAR3LPAR1LPAR2 | |
| SCHEMBL7850798 | 0.76 | LPAR3 (0.70) | LPAR3LPAR1LPAR2BTN3A1 | |
| SCHEMBL2858464 | 0.76 | LPAR3 (0.70) | LPAR3LPAR1LPAR2BTN3A1 | |
| SCHEMBL6820795 | 0.76 | LPAR3 (0.70) | LPAR3LPAR1LPAR2BTN3A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10378051-B2 | Continuous extension and deblocking in reactions for nucleic acids synthesis and sequencing | ILLUMINA CAMBRIDGE LIMITED (GB) | 2019-08-13 | — | — | US | disclosed |
| EP-3293272-A1 | CONTINUOUS EXTENSION AND DEBLOCKING IN REACTIONS FOR NUCLEIC ACID SYNTHESIS AND SEQUENCING | Illumina, Inc. (US) | 2018-03-14 | — | — | EP | disclosed |
| EP-2761026-A1 | CONTINUOUS EXTENSION AND DEBLOCKING IN REACTIONS FOR NUCLEIC ACID SYNTHESIS AND SEQUENCING | Illumina, Inc. (US) | 2014-08-06 | — | — | EP | disclosed |
| WO-2013045939-A1 | CONTINUOUS EXTENSION AND DEBLOCKING IN REACTIONS FOR NUCLEIC ACID SYNTHESIS AND SEQUENCING | ILLUMINA, INC. (US) | 2013-04-04 | — | — | WO | disclosed |
| US-20130085073-A1 | CONTINUOUS EXTENSION AND DEBLOCKING IN REACTIONS FOR NUCLLEIC ACIDS SYNTHESIS AND SEQUENCING | ILLUMINA CAMBRIDGE LIMITED (GB) | 2013-04-04 | — | — | US | disclosed |